Announcements Trials

Browse Landscape

Phase

Status

Completed 3 Terminated 2 Withdrawn 1 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 2 Uterine Cervical Dysplasia 1 Stomach Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Melanoma 1 Liver Neoplasms 1 Glioma 1 Colorectal Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Ovarian Epithelial 1 Breast Neoplasms 1

Interventions

Temozolomide 16 Radiotherapy 7 apatinib 5 anlotinib 3 Surgical Procedures, Operative 3 Chlorotoxin 3 Bevacizumab 3 Aminolevulinic Acid 3 Positron Emission Tomography Computed Tomography 2 Pemetrexed 2 Magnetic Resonance Spectroscopy 2 Lomustine 2 Irinotecan 2 Immunotherapy, Adoptive 2 Blood Specimen Collection 2 vandetanib 1 sodium thiosulfate 1 ribociclib 1 poly ICLC 1 lonafarnib 1 lentiviral minigene vaccine of COVID-19 coronavirus 1 etoposide phosphate 1 Vinblastine 1 Valproic Acid 1 Tranexamic Acid 1 Surveys and Questionnaires 1 Sunitinib 1 Rivaroxaban 1 Radiosurgery 1 Radiation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Unknown × Glioma × poly ICLC × Clear all

NCT05557240 2022-10-12

Neoantigens Phase I Trial in Newly Diagnosed Glioblastoma Patients

Shanghai 10th People's Hospital

Phase NA Unknown

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡